CN Stock MarketDetailed Quotes

300601 Shenzhen Kangtai Biological Products

Watchlist

18.70
-0.44-2.30%

Market Closed Dec 13 15:00 CST

20.89BMarket Cap40.56P/E (TTM)

Shenzhen Kangtai Biological Products Stock Forum

Moomoo AI

Jan 21 19:43

The market is likely disappointed by the EPS decline, causing investor hesitance. However, if data indicates long term growth, the sell-off could be a worthy opportunity. Investors should note 2 warning signs for Shenzhen Kangtai Biological Products.

The Three-year Shareholder Returns and Company Earnings Persist Lower as Shenzhen Kangtai Biological Products (SZSE:300601) Stock Falls a Further 4.4% in Past Week

Moomoo AI

Dec 29, 2023 18:52

Shenzhen Kangtai Biological Products' high P/S ratio seems irrational due to the dismal revenue projections. Optimistic investors expecting a business revival might be let down if the P/S ratio syncs with growth forecasts. The stock could be overinflated and may bear the risk of falling significantly.

Shenzhen Kangtai Biological Products Co., Ltd.'s (SZSE:300601) Business Is Yet to Catch Up With Its Share Price

Moomoo AI

Oct 11, 2023 22:38

The recent rise in the share price could be an expected bounce after a significant drop. However, considering its historical losses, the company's investment retains potential risk.

Shareholders in Shenzhen Kangtai Biological Products (SZSE:300601) Are in the Red If They Invested Three Years Ago

robinmc

Aug 26, 2021 21:28

Bahrain published the actual use comparison results of Pfizer mRNA vaccine and inactivated vaccine of national medicine:
To prevent infection, Pfizer effective rate 79%, Chinese medicine 45%;
Prevention of hospitalization, Pfizer effective rate of 94%, Chinese medicine 44%;
The effective rate of Pfizer was 99% and sinopharm 64%.
Prevent death, Pfizer effective rate 95%, 63%.) $Walvax Biotechnology (300142.SZ)$ $Shenzhen Kangtai Biological Products (300601.SZ)$